These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 16469479)
1. SB-271258, a major metabolite in the dog of the thiazolidinedione, rosiglitazone, stimulates protein synthesis in re-differentiated rat cardiomyocytes in vitro. Bell D; McDermott BJ Toxicol In Vitro; 2006 Sep; 20(6):808-15. PubMed ID: 16469479 [TBL] [Abstract][Full Text] [Related]
2. Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy. Bell D; McDermott BJ Eur J Pharmacol; 2005 Jan; 508(1-3):69-76. PubMed ID: 15680255 [TBL] [Abstract][Full Text] [Related]
3. Contribution of de novo protein synthesis to the hypertrophic effect of IGF-1 but not of thyroid hormones in adult ventricular cardiomyocytes. Bell D; McDermott BJ Mol Cell Biochem; 2000 Mar; 206(1-2):113-24. PubMed ID: 10839201 [TBL] [Abstract][Full Text] [Related]
4. Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum. Bell D; McDermott BJ Eur J Pharmacol; 2000 Mar; 390(3):237-44. PubMed ID: 10708729 [TBL] [Abstract][Full Text] [Related]
5. [Urotensin II induces hypertrophy of in vitro cultured neonatal rat cardiac myocytes]. Zuo HH; Hong JM; Guo HS; Wei JR; He YH; Li ZL Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):642-5. PubMed ID: 15201078 [TBL] [Abstract][Full Text] [Related]
6. [Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes]. Lu SY; Zhu MZ; Guo HT; Yu J; Wei QM Sheng Li Xue Bao; 2002 Feb; 54(1):7-11. PubMed ID: 11930233 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes. Chen SC; Cheng JJ; Hsieh MH; Chu YL; Kao PF; Cheng TH; Chan P Planta Med; 2005 Jun; 71(6):525-9. PubMed ID: 15971123 [TBL] [Abstract][Full Text] [Related]
8. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats. Rose M; Balakumar P; Singh M Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955 [TBL] [Abstract][Full Text] [Related]
9. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy. Kilić A; Javadov S; Karmazyn M J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554 [TBL] [Abstract][Full Text] [Related]
10. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo. Zhang HG; Li XH; Zhou JZ; Liu Y; Jia Y; Yuan ZB Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1276-81. PubMed ID: 17973867 [TBL] [Abstract][Full Text] [Related]
11. Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes. Wang Y; Huang BP; Luciani DS; Wang X; Johnson JD; Proud CG J Mol Cell Cardiol; 2008 Dec; 45(6):812-20. PubMed ID: 18722381 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis. Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160 [TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes. Pharaon LF; El-Orabi NF; Kunhi M; Al Yacoub N; Awad SM; Poizat C Toxicol Lett; 2017 Oct; 280():151-158. PubMed ID: 28822817 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between cardiomyocyte protein synthesis and cell viability]. Zhu XX; Niu XL; Wei J; Zhu XL; Chen SY; Chen DZ; Gao DF; Hao GH; Wang WQ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):878-80. PubMed ID: 17584660 [TBL] [Abstract][Full Text] [Related]
17. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A]. Zhou DX; Liang QS; He XX; Zhan CY Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms. Xu RX; Chen X; Chen JH; Han Y; Han BM Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):176-80. PubMed ID: 18785984 [TBL] [Abstract][Full Text] [Related]
19. Effects of dl-praeruptorin A on cultured neonatal rat ventricular cardiomyocytes with hypertrophy induced by endothelin-1. Tu X; Miao L; Kang Y; Xia H; Tu JW; Wang Q; Tu Q; Wang JM; Hao H Methods Find Exp Clin Pharmacol; 2009 May; 31(4):231-6. PubMed ID: 19557200 [TBL] [Abstract][Full Text] [Related]
20. [Effects of tetrandrine on Ang II-induced cardiomyocyte hypertrophy and p-ERK1/2 expression]. Zhou DX; Yang GT; He XX; Liu Q Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1921-4. PubMed ID: 18051908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]